TolDC Restores the Balance of Th17/Treg via Aryl Hydrocarbon Receptor to Attenuate Colitis.

Shu WangYing XuLu WangJunjie LinChenjing XuXiaojing ZhaoHong-Jie Zhang

Published in: Inflammatory bowel diseases (2024)

Activation of AhR attenuates experimental colitis by modulating the balance of TolDCs and Th17/Treg. The AhR modulation of TolDCs may be a viable therapeutic approach for CD.

Keyphrases

ulcerative colitis
signaling pathway